Sat.Nov 13, 2021 - Fri.Nov 19, 2021

article thumbnail

Omnichannel marketing is the answer but what’s the question?

World of DTC Marketing

SUMMARY: Omnichannel marketing employs the simultaneous implementation of channels across personal, non-personal, and media and addresses the integrated needs of multiple stakeholders – consumers/patients, healthcare professionals, and payers. Sounds good but is that the answer? There is no doubt that healthcare is the middle of an evolution not seen in over 30 years.

Marketing 253
article thumbnail

A new way to access scientific papers?

Fierce Pharma

A new way to access scientific papers? admin. Mon, 11/15/2021 - 12:01.

147
147
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Highly Cited Researchers 2021: How nations and institutions foster exceptional performance

Clarivate

Today we unveil our annual list of Highly Cited Researchers. We congratulate some 6,600 scientists and social scientists for demonstrating significant influence among their peers in their chosen field (or fields) through the publication of multiple highly cited papers during the last decade. These highly cited papers rank in the top 1% by citations for field and year from 2010 – 2020.

article thumbnail

The Difference Between a Full Line Sales Rep and an Associate Sales Rep

New to Medical Device Sales

You can listen here: [link] You can watch here: [link] What’s the difference between a full line sales rep (TM ) and an associate sales rep (ASR)? Associate Sales Rep (ASR) The job of an associate rep is to make the full line reps life easier. They will be doing all the things the TM doesn’t want/have time to do. Majority of the times the ASR will be spending their time: Covering cases Running trays/equipment Helping with territory daily task There will be other duties for the ASR, but from my e

Sales 130
article thumbnail

AI Strategies for Sales Managers: How to Cut Down on Tedious Admin Work

What if you could help your sellers stop wasting 72% of their day on non-selling activities and focus on bringing in revenue? Incorporating AI in your enablement workflows can help you cut down on busy work, get projects done faster, and let your team (and you!) focus on making a bigger impact. We put together this guide to show you how to use AI to cut time and costs for projects, including collateral creation, development of training videos, and automating tedious processes.

article thumbnail

It’s getting harder to launch a new drug to physicians

World of DTC Marketing

SUMMARY: Physicians are tired and overwhelmed with medical information on new drugs. They don’t have the time to sit in the office and search for more information, and they feel that pharma is giving them “too much” information. An exciting development presented itself. A client launched an Oncology drug based on extensive research with physicians, but the results were not that good during a post-launch evaluation.

article thumbnail

Episode 70 – In the C-Suite with Patricia Zilliox, CEO, Eyevensys

Medical Device Success

Reading time: 2 – 3 minutes. Today’s guest is Patricia Zilliox, CEO of Eyevensys, a clinical stage biotechnology company based in Paris, France and Dallas, Texas. Patricia is running a very exciting startup that combines a medical device and gene-therapy that is targeting some of the biggest causes of blindness. The idea behind this biotechnology is the brainchild of Founder Francine Behar-Cohen, MD, PhD.

More Trending

article thumbnail

How pharma can successfully map the patient journey | Prognos Health

Prognos Health

Understanding the longitudinal patient journey — from symptoms to testing, to diagnosis and treatment — is a standard and essential part of any life science company’s business practice.

article thumbnail

Moderna is corporate greed at its worst

World of DTC Marketing

SUMMARY: The U.S. government has provided Moderna with nearly $10 billion in taxpayer money for research and development and the purchase of 500 million doses of this mRNA COVID-19 vaccine. This includes almost the entire cost of clinical development. Additionally, Moderna used patents and non-exclusive rights that the U.S. government made available to them to make this COVID-19 vaccine.

article thumbnail

5 Common Medical Sales Mistakes to Avoid

Axxelus

Mistakes happen in every profession. The medical sales industry is no exception. However, some errors can be costlier than others when it comes to medical sales mistakes. In today’s post, we’ll examine some common sales mistakes, why mistakes happen, and some strategies for reducing your risks.

article thumbnail

Guided by science to accelerate innovation

Clarivate

Women leaders at Clarivate like Ann Graul play a key role in accelerating innovation in the quest for answers to COVID-19 issues. Watch their story. The global COVID-19 pandemic that began in early 2020 turned the world as we knew it upside down, bringing unimagined challenges and exacerbating existing struggles. It impacted how people work and the progress and speed of broader problem-solving.

Leads 59
article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

3 Steps to Faster Patient Journey Mapping for Pharma Brand Success

Prognos Health

Understanding the longitudinal patient journey — from symptoms to testing, to diagnosis and treatment — is a standard and essential part of any life science company’s business practice. To optimally position your therapy in the market, you need insight into the following questions: How does the disease progress that our therapy is designed to treat?

article thumbnail

AbbVie continues to be what’s wrong with big pharma

World of DTC Marketing

SUMMARY: AbbVie continues to profit from Americans by repeatedly raising U.S. prices on its widely-used Humira rheumatoid arthritis drug while cutting the price abroad. AbbVie exploits the U.S. patent system to fend off competitors and increased the price of Humira to $77,000 for a year’s supply, while the price of its cancer drug Imbruvica was raised to $181,529 per year.

Pharma 202
article thumbnail

WHY PM MODI ADDRESSED, INDIA AS THE PHARMACY OF THE WORLD

Pharmatutor

WHY PM MODI ADDRESSED, INDIA AS THE PHARMACY OF THE WORLD. Recently, during inauguration of Global Innovation Summit of the pharmaceuticals sector Indian Prime Minister Shri Narendra Modi addressed, India as the Pharmacy of the world. He said that our definition of wellness is not limited by physical boundaries. We have exported life-saving medicines and medical equipment to over 150 countries during the initial phase of the pandemic.

article thumbnail

How Leaders Can Call for Return To Office Without De-motivating Their People Using T.I.E.

ALULA

“ Leaders don’t force people to follow, they invite them on a journey ” – Charles S. Lauer. This article is co-authored by Dee Conway and Bridget Russell, Ed.D. There’s been a great deal of dialogue on the return to office (or RTO). From business need, to timing, to individual impacts, the discussion has been… robust, to put it lightly. But what if you as a leader are considering whether it’s time for your team to return.

Leads 52
article thumbnail

Optimizing Clinical Supply Strategy: Navigating Challenges & Finding Your Ideal Model

article thumbnail

Highlights from The Data Ecosystem in 2025 - Prognos Health

Prognos Health

Datavant , the leader in helping healthcare organizations securely connect their data and a Prognos Health partner, recently held its Future of Health Data Summit in Washington DC. This in-person event brought healthcare leaders together to discuss emerging opportunities and challenges around the use of health data to improve patient outcomes.

article thumbnail

Showing the value of regulatory intelligence in pharma [Podcast]

Clarivate

In this episode of Conversations in Healthcare , Carolyn Hynes from AstraZeneca discusses the importance of regulatory intelligence. In this episode of Conversations in Healthcare, Mike Ward, Global Head of Thought Leadership, Life Science & Healthcare at Clarivate, speaks with Carolyn Hynes, Director of Regulatory Intelligence at AstraZeneca and Celine Rodier, Senior Health Policy Manager at Clarivate about the importance of regulatory intelligence and its potential return investment for co

Pharma 52
article thumbnail

How to Create Content People Will Actually Want to Read

LEVO Health

In the medical marketing world, it can sometimes be challenging to produce entertaining content that your patients will want to read and engage with. However, there are plenty of tips and tricks you can incorporate into your content to keep patients engaged and coming back for more. Tips for Creating Content Your Patients Want to Read. Do you want the content your practice creates to be read, shared, or commented on?

article thumbnail

How Revosuite can help you mitigate the risk of your field force turnover?

Revosuite

For pharma companies, medical reps turnover is very costly, from recruitment to training, the process of replacement and handover costs the company money, time, and most importantly momentum. But unfortunately, that's not all! When a medical rep leaves a company, not only does he/she takes institutional knowledge with him/her, but also a range of retinotopic intelligence, customer relationships, and sales.

article thumbnail

How Machine Learning Drives Clinical Trial Efficiency

Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.

article thumbnail

Highlights from The Data Ecosystem in 2025

Prognos Health

Datavant , the leader in helping healthcare organizations securely connect their data and a Prognos Health partner, recently held its Future of Health Data Summit in Washington DC. This in-person event brought healthcare leaders together to discuss emerging opportunities and challenges around the use of health data to improve patient outcomes. Prognos CEO Sundeep Bhan was a featured panelist in a session titled The Data Ecosystem in 2025 , which also included leaders from CVS Health, Komodo Heal

article thumbnail

What Are Virtual Booths? And How To Master Virtual Exhibition Booths

Infuse Medical

Once a buzzing exhibition event that drew companies from near and far, trade shows have since pivoted to virtual booths in response to the COVID-19 global pandemic. Despite this pivot, the objective remains the same – provide companies and exhibitors space and opportunity to engage with attendees, inform them about their brand and products, and generate leads.

article thumbnail

2021 New Drug Approvals: Review of FDA and EMA Marketing Authorisations

Tribeca Knowledge

I n another year of considerable turbulence for pharmaceuticals, with COVID-19 continuing to disrupt business strategies and patient access to medicines, regulators and companies alike are finding ways to keep the approval flow coming. The trend for 2021 new drug approvals in both the US and the European Union, the two most important launching pads for innovative medicines worldwide, has more than kept pace with 2020.

article thumbnail

How RPM Companies Can Leverage the New Remote Therapeutic Monitoring CPT Codes Expected in 2022

Nixon Gwilt Law

If you are in the digital health industry, particularly the remote patient monitoring (“RPM”) space, you have likely heard of the remote therapeutic monitoring (“RTM”) codes finalized in the 2022 Medicare Physician Fee Schedule Final Rule (the “Final Rule”). With these new codes set to go into effect January 1, 2022, RPM vendors already in the remote monitoring arena should start preparing now for how they can take advantage of this new reimbursement opportunity.

article thumbnail

How to Prove Marketing Value: Demonstrate Content ROI and Contribution to Sales

Every marketer knows how important it is to prove their efforts drive sales opportunities, but that’s easier said than done. When problems like sales and marketing misalignment, lack of data, and wasted efforts persist, marketers can’t measure, prove, or increase their impact on revenue at a time when demonstrating marketing value is critical. Using analyst and expert data, this guide to marketing impact and content attribution explains: How B2B buyers use content The most common types of conten

article thumbnail

National health plan increases competitive overlap to 70% for 900+ Medicare Advantage networks in under 12 months

Clarify Health

Medicare Advantage is expected to reach 40% penetration by 2025. By 2023, available annual profit pools will range from $11 billion to $13 ­billion, making Medicare Advantage the single biggest driver of profit growth for health care insurance providers ¹. For health plans looking to grow their share of this market, they need to ensure that they’re as competitive as possible.

article thumbnail

ISO 9000 series requirements in Quality Management Systems : A REVIEW

Pharmatutor

ISO 9000 series requirements in Quality Management Systems : A REVIEW. About Author. Vikas Kumar Prajapati. Organization - Bansal College of Pharmacy, Bhopal(M.P.). Email: vikasprajapati8417@gmail.com. admin. Mon, 11/15/2021 - 16:10. Tags. Articles. Review Articles.

article thumbnail

Don’t Drop Your Sales Baton

Toolyt

“If everything seems under control, you're not going fast enough,” says Mario Andretti, one of the successful car racing drivers. In the fast-changing world, it is the pace that matters. Everything should happen swiftly but accurately especially in the Business and Sales World. We all would have seen the track relay race right from the school days.

Sales 52
article thumbnail

3 Practical Steps to Better Protect Your Healthcare Business (and Reputation) from Data Breaches

Nixon Gwilt Law

“.almost every month last year more than 1 million people were affected by data breaches at health-care organizations.” — US Dept of Health and Human Services. Over the past year, the healthcare industry has widely embraced the use of telemedicine and digital health platforms largely as a response to the COVID-19 Public Health Emergency. Not surprisingly, the industry also saw a significant rise in the number of cyberattacks.

article thumbnail

How to Stay Competitive in the Evolving State of Martech

Marketing technology is essential for B2B marketers to stay competitive in a rapidly changing digital landscape — and with 53% of marketers experiencing legacy technology issues and limitations, they’re researching innovations to expand and refine their technology stacks. To help practitioners keep up with the rapidly evolving martech landscape, this special report will discuss: How practitioners are integrating technologies and systems to encourage information-sharing between departments and pr

article thumbnail

National health plan increases competitive overlap to 70% for 900+ Medicare Advantage networks in under 12 months

Clarify Health

Medicare Advantage is expected to reach 40% penetration by 2025. By 2023, available annual profit pools will range from $11 billion to $13 ­billion, making Medicare Advantage the single biggest driver of profit growth for health care insurance providers¹. For health plans looking to grow their share of this market, they need to ensure that [.].

article thumbnail

Daniella Gilboa

Cadensee

Daniella Gilboa. CEO, AIVF. CEO of AIVF, a company that is out to transform the fertility and IVF treatment journey. Daniella was an embryologist for more than 15 years before establishing AIVF. . Show Notes. 01:15 What are the most memorable milestones that brought you to where you are today? 02:58 What is the driving force behind your passion for Health Technology?

article thumbnail

Don’t Drop Your Sales Baton

Toolyt

“If everything seems under control, you're not going fast enough,” says Mario Andretti, one of the successful car racing drivers. In the fast-changing world, it is the pace that matters. Everything should happen swiftly but accurately especially in the Business and Sales World. We all would have seen the track relay race right from the school days.

Sales 52
article thumbnail

Hip & knee implant manufacturers – The value creation opportunity

Curzon Consulting

15th November 2021 1 Minutes. If hip and knee implant manufacturers want to stay relevant, and “move the needle” on value creation, they need to play big or go home! An aging (ageing) population is driving absolute sales, but over the past few years, primary hip and knee procedures have become commoditised, which has resulted in margins being squeezed for both hospital providers and implant manufacturers.

article thumbnail

European Clinical Supply Planning: Balancing Cost, Flexibility and Time